Lower Trapezius Tendon Transfer vs Partial Cuff Repair in Massive Rotator Cuff Tears
TENET
TransfEr of the Lower Trapezius Tendon Versus Partial Cuff Repair Trial - TENET Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Very large tears of the shoulder tendons (the 'rotator cuff') that are not surgically repairable and in the absence of significant shoulder arthritis are common in older patients, and are associated with significant pain and functional limitations. Transfer of one particular tendon called the trapezius is becoming popular as a means of restoring function and improving pain in patients with massive rotator cuff tears. This tendon is appealing for transfer, as it has a similar line of pull to the infraspinatus (one of the rotator cuff tendons). There is currently no clear surgical consensus regarding the optimal treatment of patients with symptomatic massive irreparable rotator cuff tears that are appropriate candidates for joint salvage treatment, and no high level of evidence studies to guide clinical decision making have been published. A pilot study is required prior to the development of a full-scale trial to assess its feasibility and recruitment across clinical sites, to determine protocol adherence (errors in randomization), and patient retention over a 12-month period. The main objective of this pilot trial is to assess a composite measure of feasibility including recruitment, protocol adherence, and patient retention at one-year. The secondary objectives, currently exploratory only, are to determine the clinical outcomes of lower trapezius tendon transfer versus arthroscopic rotator cuff partial repair and biceps tenodesis/tenotomy on clinical outcome measures, shoulder function, adverse events and reoperation rates at two-years. This pilot study is a parallel-group multicentre randomized controlled trial with participating sites across Canada, and one site in the United States.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
July 4, 2025
July 1, 2025
2.4 years
May 9, 2025
July 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of Recruitment and Follow-Up
Assess the feasibility of this pilot trial as determined by: (1) Recruitment rate of 6 per month across study centres; (2) 3 or fewer crossovers for enrolled participants; and (3) 85% of participants have a full adherence to protocol.
1-year
Secondary Outcomes (9)
The Western Ontario Rotator Cuff Score (WORC)
2-years post-operative
Constant Score
2-years post-operative
American Shoulder and Elbow Surgeons Standardized Shoulder Assessment form (ASES)
2-years post-operative
Subjective Shoulder Value
2-years post-operative
EuroQol EQ-5D-5L
2-years post-operative
- +4 more secondary outcomes
Study Arms (2)
Lower Trapezius Tendon Transfer
ACTIVE COMPARATORThe Lower Trapezius Tendon Transfer procedure involves transferring one of the other tendons located just outside the shoulder (the 'lower trapezius') and attaching this to the upper part of the arm bone, in the place of the torn rotator cuff tendon.
Partial Rotator Cuff Repair
ACTIVE COMPARATORThe rotator cuff repair procedure involves reattaching the torn tendon(s) back to the upper part of the arm bone.
Interventions
This procedure is performed arthroscopically. The lower trapezius tendon is harvested from the back of the shoulder blade. A donor tendon is then used to extend the lower trapezius tendon so that it can reach the top of the arm bone. The tendon graft is then attached to the top of the arm bone, while the other end remains attached to the lower trapezius tendon itself. Any additional concomitant procedures (e.g. debridement, biceps release…etc.) may be performed as well.
This procedure is performed arthroscopically. The massive rotator cuff tear will be repaired by securing the loose tendon ends to the bone with suture anchors. The surgeon may also conduct a debridement of the area to remove any broken-down cartilage and tissues. Finally, the biceps tendon in will be further inspected for any damage or inflammatory changes, and the tendon may be released at the discretion of the surgeon (known as a biceps tenodesis or tenotomy depending on technique).
Eligibility Criteria
You may qualify if:
- Adult male and females over 18 years of age
- MRI confirmed diagnosis of massive rotator cuff tears defined using the Schumaier 2020 definition of massive cuff tears which includes the following criteria:
- Retraction of the tendons to the glenoid rim, measured in either the coronal or axial plane
- Greater than or equal to 67% of the greater tuberosity exposed in the axial plane
- Features of irreparability of their rotator cuff tendon tear including:
- Tendon retraction equal to or greater than 3cm16
- Remnant tendon length of supraspinatus \<15mm (as measured on coronal sequence of shoulder MRI)62
- Goutallier grade 3 or 4 fatty infiltration of the supraspinatus
- An external rotation lag present on clinical exam. A positive external rotation lag will be considered as inability to perform external rotation with or against gravity.
- Provision of informed consent
You may not qualify if:
- Patients with complete subscapularis tears
- Patients with concomitant injuries of the affected shoulder
- Previous surgery on the affected shoulder
- Hamada grade 3 or above changes on plain films of the shoulder
- Substantial shoulder comorbidity (e.g. Bankart lesion or osteoarthritis \[defined as joint space narrowing or osteophytes present on radiographs and confirmed at the time of arthroscopy\])
- Substantial medical comorbidity that could impact the effectiveness of surgical intervention
- Inability to speak English or French
- Patients that will likely have difficulty with maintaining follow-up in the opinion of the evaluators (no fixed address, unwilling to be followed, incarcerated individuals, etc.)
- Cases involving litigation or workplace insurance claims
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Lapner, MD FRCSC
The Ottawa Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2025
First Posted
July 4, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2029
Last Updated
July 4, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will be be shared with other researchers unless requested and an agreement is in place. Only aggregate data will be made public (overall study results).